75
Participants
Start Date
December 1, 2017
Primary Completion Date
September 5, 2021
Study Completion Date
May 6, 2022
PGx test
A laboratory developed genetic test that differentiates common and uncommon alleles in genes that have been previously identified as being involved in either the metabolism or response of drugs used in the treatment of depression and/or anxiety. The results are provided as a report that contains information related to the allele status of the patient's genes, translates this into a phenotype, and relates this phenotype to recommendation classes for drugs.
University of Michigan, Ann Arbor
University of Michigan
OTHER